Target Name: NR0B1
NCBI ID: G190
Review Report on NR0B1 Target / Biomarker Content of Review Report on NR0B1 Target / Biomarker
NR0B1
Other Name(s): Nuclear receptor 0B1 | NROB1 | DSS | AHX | nuclear receptor DAX-1 | AHCH | NR0B1_HUMAN | DAX-1 | DSS-AHC critical region on the X chromosome protein 1 | AHC | nuclear hormone receptor | DAX1 | truncated nuclear receptor subfamily 0 group B member 1 | GTD | Nuclear receptor subfamily 0 group B member 1 | HHG | nuclear receptor subfamily 0 group B member 1 | Nuclear receptor DAX-1 | SRXY2

NR0B1: A Drug Target / Disease Biomarker

NR0B1 is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and immune system. Its function is not well understood, but it is known to play a role in the development and progression of several diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. As a drug target or biomarker, NR0B1 is of interest to researchers because it can be targeted with small molecules or antibodies to treat these diseases.

One of the promising aspects of NR0B1 is its potential as a drug target is its involvement in several neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by the progressive loss of brain cells and their progressive replacement with neurodegeneration, leading to the observed symptoms.NR0B1 has been shown to be involved in the development and progression of neurodegenerative disorders by its expression in the affected tissues and its role in the development of neurofibrillary tangles and neuroglial cells.

In addition to its involvement in neurodegenerative disorders, NR0B1 has also been shown to be involved in the development and progression of autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. These disorders are characterized by an overreactive immune system that leads to inflammation and damage to body tissues.NR0B1 has been shown to play a role in the development and progression of autoimmune diseases by its expression in the affected tissues and its role in the regulation of immune cell function.

Furthermore, NR0B1 has also been shown to be involved in the development and progression of cancer. Cancer is a disease that can be caused by a variety of factors, including genetic mutations, UV exposure, and exposure to radiation.NR0B1 has been shown to play a role in the development and progression of cancer by its expression in the affected tissues and its role in the regulation of cell growth and apoptosis.

Despite the promising involvement of NR0B1 in several diseases, its function and its role in the development and progression of these diseases are not well understood. Further research is needed to determine the exact role of NR0B1 in these diseases and to explore its potential as a drug target or biomarker.

In conclusion, NR0B1 is a protein that has been shown to be involved in the development and progression of several diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. As a drug target or biomarker, NR0B1 is of interest to researchers because it can be targeted with small molecules or antibodies to treat these diseases. Further research is needed to determine the exact role of NR0B1 in these diseases and to explore its potential as a drug target or biomarker.

Protein Name: Nuclear Receptor Subfamily 0 Group B Member 1

Functions: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)

The "NR0B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NR0B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3 | NSUN4 | NSUN5 | NSUN5P1 | NSUN5P2 | NSUN6 | NSUN7 | NT5C | NT5C1A | NT5C1B